Filing Details
- Accession Number:
- 0000711377-17-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-25 13:15:01
- Reporting Period:
- 2017-08-21
- Accepted Time:
- 2017-08-25 12:15:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189021 | Edward Bradley | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-21 | 5,000 | $65.08 | 81,512 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 5, 2017
Billionaire Hedge Funds
